全文获取类型
收费全文 | 7385篇 |
免费 | 591篇 |
国内免费 | 354篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 65篇 |
妇产科学 | 16篇 |
基础医学 | 251篇 |
口腔科学 | 37篇 |
临床医学 | 747篇 |
内科学 | 3671篇 |
皮肤病学 | 16篇 |
神经病学 | 222篇 |
特种医学 | 692篇 |
外国民族医学 | 1篇 |
外科学 | 841篇 |
综合类 | 1048篇 |
预防医学 | 123篇 |
眼科学 | 70篇 |
药学 | 241篇 |
6篇 | |
中国医学 | 39篇 |
肿瘤学 | 181篇 |
出版年
2024年 | 5篇 |
2023年 | 136篇 |
2022年 | 171篇 |
2021年 | 360篇 |
2020年 | 339篇 |
2019年 | 284篇 |
2018年 | 343篇 |
2017年 | 258篇 |
2016年 | 316篇 |
2015年 | 341篇 |
2014年 | 595篇 |
2013年 | 583篇 |
2012年 | 417篇 |
2011年 | 474篇 |
2010年 | 404篇 |
2009年 | 432篇 |
2008年 | 386篇 |
2007年 | 447篇 |
2006年 | 352篇 |
2005年 | 289篇 |
2004年 | 258篇 |
2003年 | 207篇 |
2002年 | 217篇 |
2001年 | 146篇 |
2000年 | 100篇 |
1999年 | 86篇 |
1998年 | 111篇 |
1997年 | 97篇 |
1996年 | 34篇 |
1995年 | 52篇 |
1994年 | 36篇 |
1993年 | 14篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1987年 | 2篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有8330条查询结果,搜索用时 656 毫秒
1.
Aliyah Hussein Kiran Sran Imran Ali Janine Woellner Helen Wilcox Stephen D. Marks Helen Jones Chris Callaghan 《Pediatric transplantation》2020,24(4)
Transplant ureteric stent insertion reduces the incidence of MUCs, but it is not known whether routine PSRGU is needed to detect unmasked MUCs. This study evaluated whether routine PSRGU in the pRTR is a useful tool to identify MUCs before they become clinically apparent. A retrospective analysis was undertaken of the clinical outcomes following elective stent removal from pediatric kidney‐only transplant recipients at two London centers between 2012 and 2016. Our policy was to perform PSRGU either routinely or urgently if there were concerning symptoms or biochemical evidence of renal allograft dysfunction. Elective stent removal was performed in 86% (97 of 113 pRTR), and 75 (77%) of whom had routine PSRGU at a median (IQR) of 6 (2‐8) days after stent removal. There were changes to management in 3 (4%) of pRTR with PSRGU identifying no MUC. Nineteen patients (25%) had urgent PSRGU, most commonly due to renal allograft dysfunction, at a median (IQR) of 5.5 (2.7‐12.3) days after stent removal. Of these, two pRTR required ureteric intervention. For our current practice of removing transplant stents at 4‐6 weeks post‐transplantation, our study has found no evidence to support routine PSRGU after elective stent removal. 相似文献
2.
3.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
4.
5.
6.
《Journal of vascular and interventional radiology : JVIR》2020,31(4):630-634
PurposeTo retrospectively evaluate the safety and effectiveness of the Covera stent graft (SG) for the treatment of dysfunctional or thrombosed arteriovenous grafts (AVGs).Materials and MethodsWithin 29 months (February 2016–August 2018), 79 patients underwent Covera SG placement in the authors’ department for the treatment of dysfunctional AVGs. Data were available for 64 patients who underwent 64 procedures, using 64 devices. Minimum follow-up was 6 months, unless reintervention occurred. Mean follow-up was 277 days (6–923 days). Treatment characteristics were 51 cases with venous-graft anastomosis (VGA) stenosis (79.7%), 13 cases of puncture zone stenosis (20.3%), 14 cases of in SG stenosis (21.9%), 8 cases of pseudoaneurysm treatment (12.5%) (1 treatment area might have had more than 1 characteristic). Thirty-six patients presented with thrombosis (56.2%), and 31 of 64 case were de novo treatment areas (48.4%). Primary outcome measurements were technical success and post-intervention primary patency (PIPP) at 6 months, whereas secondary outcome measurements included factors influencing primary outcome.ResultsTechnical success was 100%. Median PIPP was 336 days, and 73.6% of treatment areas were patent at 6 months. There were no significant differences in terms of PIPP when de novo treatment areas were compared with restenotic areas (519 vs. 320 days, respectively; P = .1); patients who presented with versus those who presented without thrombosis (320 vs. 583 days, respectively; P = .07); puncture zone stenosis or elsewhere (329 vs. 686 days, respectively; P = .52); and VGA stenosis or elsewhere (336 vs. 335 days, respectively; P = .9).ConclusionsUse of the Covera SG for AVG treatment was safe and effective in every type of treatment area presented in this retrospective analysis. 相似文献
7.
8.
9.
Summary A new modification of microvenous anastomosis, which has increased patency rates while simultaneously decreasing the difficulty of the procedure, is presented in this paper. The primary purpose of this study was to compare the classical and the temporary stent techniques of microvenous anastomosis. Because of problems such as mixing and tangling of strings during insertion and tying of the last four sutures while applying the temporary stent technique, we decided to modify the procedure. The silastic tube was removed through an incision (venotomy), distant from the actual suture line. This modified technique and the other above mentioned techniques were carried out on rat femoral veins. The results indicate that this modification has increased patency rates, shortened the time of anastomosis and facilitated the procedure. 相似文献
10.
食管支架置入术的临床应用 总被引:4,自引:0,他引:4
目的探讨食管支架置入术对良、恶性食管狭窄和食管瘘的治疗方法、疗效和并发症的处理。方法对55例不同原因所致良、恶性食管狭窄和食管瘘患者采用食管金属支架置入术。结果食管狭窄的主要症状吞咽困难、呛咳得到改善,近期疗效达100%。出现的并发症主要为疼痛和大便隐血,发生率分别为100%和92.7%,其余依次为胃食管返流、食管再狭窄、支架脱落,经过治疗后得到缓解或消失。结论金属支架置入术是治疗中晚期食管癌、狭窄的有效方法之一,对食管良性狭窄和瘘效果亦好。并发症可以预防,处理后大部分缓解。 相似文献